Purchases and Sales Made in Q3 2022 in Acelrx Pharmaceuticals Inc (ACRX)
This table provides information about the institutional ownership of Acelrx Pharmaceuticals Inc (ACRX) during Q3 2022. The information is specifically focused on institutions that hold shares of ACELRX PHARMACEUTICALS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
832K+ 22.26% |
$166K - $291K
|
4.57M
$5.16M
|
|
Nov 03, 2022
Q3 2022
|
Texas Capital Bank Wealth Management Services Inc
|
BUY
|
- |
350K+ 437.5% |
$70K - $122K
|
430K
$486K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
197KNew |
$39.4K - $69K
|
197K
$223K
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
109KNew |
$21.8K - $38.1K
|
109K
$123K
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
84.5K+ 7.84% |
$16.9K - $29.6K
|
1.16M
$1.31M
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
65.3KNew |
$13.1K - $22.9K
|
65.3K
$73.8K
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
61.9KNew |
$12.4K - $21.6K
|
61.9K
$69.9K
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
61.9KNew |
$12.4K - $21.6K
|
61.9K
$69.9K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
53K+ 982.15% |
$10.6K - $18.6K
|
58.4K
$66K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
36.5K+ 63.79% |
$7.31K - $12.8K
|
93.8K
$106K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
29K+ 250.27% |
$5.8K - $10.2K
|
40.6K
$45.9K
|
|
Oct 11, 2022
Q3 2022
|
Juncture Wealth Strategies, LLC
|
BUY
|
- |
28.6KNew |
$5.72K - $10K
|
28.6K
$32.3K
|
|
Dec 02, 2022
Q3 2022
|
Values First Advisors, Inc.
|
BUY
|
- |
27K+ 3.52% |
$5.4K - $9.45K
|
794K
$897K
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
20K+ 1.04% |
$4K - $7K
|
1.95M
$2.2M
|
|
Nov 03, 2022
Q3 2022
|
Creative Planning
Overland Park, KS |
BUY
|
- |
15.5KNew |
$3.1K - $5.43K
|
15.5K
$17.5K
|
|
Nov 09, 2022
Q3 2022
|
Ausdal Financial Partners, Inc.
Davenport, IA |
BUY
|
- |
10K+ 62.5% |
$2K - $3.5K
|
26K
$29.4K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
8.32K+ 21.8% |
$1.66K - $2.91K
|
46.5K
$52.6K
|
|
Oct 31, 2022
Q3 2022
|
Apricus Wealth, LLC
Beaufort, SC |
BUY
|
- |
5K+ 3.83% |
$1K - $1.75K
|
136K
$153K
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
2.34K+ 1172.0% |
$469 - $820
|
2.54K
$2.87K
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
450+ 1.84% |
$90 - $158
|
24.9K
$28.2K
|
|
Nov 03, 2022
Q3 2022
|
Global Retirement Partners, LLC
|
BUY
|
- |
23New |
$4.6 - $8.05
|
23
$26
|
|
Nov 14, 2022
Q3 2022
|
Northwestern Mutual Wealth Management CO
|
SELL
|
- |
-5- 20.0% |
$1 - $1.75
|
20
$22.6
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
SELL
|
- |
-1.65KClosed |
$330 - $578
|
0
$0
|
|
Nov 10, 2022
Q3 2022
|
Sigma Planning Corp
Ann Arbor, MI |
SELL
|
- |
-2.9K- 22.48% |
$580 - $1.01K
|
10K
$11.3K
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-4.26K- 17.94% |
$851 - $1.49K
|
19.5K
$22K
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-5K- 1.11% |
$1K - $1.75K
|
444K
$501K
|
|
Oct 17, 2022
Q3 2022
|
Cambridge Investment Research Advisors, Inc.
|
SELL
|
- |
-7K- 27.8% |
$1.4K - $2.45K
|
18.2K
$20.5K
|
|
Nov 07, 2022
Q3 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-47.1K- 39.42% |
$9.42K - $16.5K
|
72.4K
$81.8K
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-50K- 16.49% |
$10K - $17.5K
|
253K
$286K
|
|
Nov 14, 2022
Q3 2022
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-71.9K- 55.0% |
$14.4K - $25.2K
|
58.8K
$66.5K
|